[Clinical effectiveness of the treatment of systemic lupus erythematosus with preparations of the methylxanthine group and T-activin].
D000328:Adult; D001327:Autoimmune Diseases / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy*; D008297:Male; D010455:Peptides / Q000008:administration & dosage / Q000627:therapeutic use*; D013806:Theophylline / Q000008:administration & dosage / Q000627:therapeutic use*; D013949:Thymus Extracts / Q000008:administration & dosage / Q000627:therapeutic use*
D010455:Peptides; D013949:Thymus Extracts; C036191:T-activin; D013806:Theophylline
Klinicheskaia éffektivnost' terapii sistemnoĭ krasnoĭ volchanki preparatami metilksantinovogo riada i taktivinom.